108 related articles for article (PubMed ID: 32644225)
21. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
22. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
[TBL] [Abstract][Full Text] [Related]
23. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.
White RE; Wade-Martins R; James MR
Mol Ther; 2002 Apr; 5(4):427-35. PubMed ID: 11945070
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
26. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
27. Generation of high-titer defective HSV-1 vectors.
Neve RL; Lim F
Curr Protoc Neurosci; 2013 Jan; Chapter 4():Unit 4.13. PubMed ID: 23315945
[TBL] [Abstract][Full Text] [Related]
28. Engineering HSV-1 Vectors for Gene Therapy.
Goins WF; Huang S; Hall B; Marzulli M; Cohen JB; Glorioso JC
Methods Mol Biol; 2020; 2060():73-90. PubMed ID: 31617173
[TBL] [Abstract][Full Text] [Related]
29. In vivo episomal maintenance of a herpesvirus saimiri-based gene delivery vector.
Smith PG; Coletta PL; Markham AF; Whitehouse A
Gene Ther; 2001 Dec; 8(23):1762-9. PubMed ID: 11803395
[TBL] [Abstract][Full Text] [Related]
30. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
[TBL] [Abstract][Full Text] [Related]
31. Sorting vector producer cells for high transgene expression increases retroviral titer.
Beaudoin EL; Bais AJ; Junghans RP
J Virol Methods; 2008 Mar; 148(1-2):253-9. PubMed ID: 18249448
[TBL] [Abstract][Full Text] [Related]
32. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
33. Single Plasmid-Based, Upgradable, and Backward-Compatible Adenoviral Vector Systems.
Liu H; Lu Z; Zhang X; Guo X; Mei L; Zou X; Zhong Y; Wang M; Hung T
Hum Gene Ther; 2019 Jun; 30(6):777-791. PubMed ID: 30793964
[TBL] [Abstract][Full Text] [Related]
34. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
35. Plasmovirus: replication cycle of a novel nonviral/viral vector for gene transfer.
Morozov VA; Noguiez-Hellin P; Laune S; Tamboise E; Salzmann JL; Klatzmann D
Cancer Gene Ther; 1997; 4(5):286-93. PubMed ID: 9345600
[TBL] [Abstract][Full Text] [Related]
36. Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.
Dubensky TW; Driver DA; Polo JM; Belli BA; Latham EM; Ibanez CE; Chada S; Brumm D; Banks TA; Mento SJ; Jolly DJ; Chang SM
J Virol; 1996 Jan; 70(1):508-19. PubMed ID: 8523564
[TBL] [Abstract][Full Text] [Related]
37. Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector.
Ohtsuka J; Fukumura M; Tsurudome M; Hara K; Nishio M; Kawano M; Nosaka T
Gene Ther; 2014 Aug; 21(8):775-84. PubMed ID: 24942630
[TBL] [Abstract][Full Text] [Related]
38. A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors.
Pechan PA; Fotaki M; Thompson RL; Dunn R; Chase M; Chiocca EA; Breakefield XO
Hum Gene Ther; 1996 Oct; 7(16):2003-13. PubMed ID: 8930661
[TBL] [Abstract][Full Text] [Related]
39. Development of herpesvirus-based episomally maintained gene delivery vectors.
Calderwood MA; White RE; Whitehouse A
Expert Opin Biol Ther; 2004 Apr; 4(4):493-505. PubMed ID: 15102599
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
